A resolution expressing the sense of the Senate that effective treatment and access to care for individuals with psoriasis and psoriatic arthritis should be improved.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
97pct
119d open
vs 634 other SRES bills in the 109th — cohort avg 11d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2006 · year_end · Medical/Disease Research/Clinical Labs
H. Con. Res. 340 H.R. 6214 S. Res. 420
Client expense: Not reported · Firm income: $80,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institute on Alcohol Abuse & Alcoholism (NIAA), Natl Institutes of Health (NIH), SENATE
| Democratic |
| NJ |
| Ron Wyden | Democratic | OR |
| Tim Johnson | Democratic | SD |